Filip Morys1, Mahsa Dadar1,2, Alain Dagher1. 1. Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada. 2. Department of Radiology and Nuclear Medicine, Faculty of Medicine, Laval University, Québec, Canada.
Abstract
CONTEXT: Chronic obesity is associated with several complications, including cognitive impairment and dementia. However, we have only piecemeal knowledge of the mechanisms linking obesity to central nervous system damage. Among candidate mechanisms are other elements of obesity-associated metabolic syndrome, such as hypertension, dyslipidemia, and diabetes, but also systemic inflammation. While there have been several neuroimaging studies linking adiposity to changes in brain morphometry, a comprehensive investigation of the relationship has so far not been done. OBJECTIVE: To identify links between adiposity and cognitive dysfunction. METHODS: This observational cohort study (UK Biobank), with an 8-year follow-up, included more than 20 000 participants from the general community, with a mean age of 63 years. Only participants with data available on both baseline and follow-up timepoints were included. The main outcome measures were cognitive performance and mediator variables: hypertension, diabetes, systemic inflammation, dyslipidemia, gray matter measures, and cerebrovascular disease (volume of white matter hyperintensities on magnetic resonance imaging). RESULTS: Using structural equation modeling, we found that body mass index, waist-to-hip ratio, and body fat percentage were positively related to higher plasma C-reactive protein, dyslipidemia, hypertension, and diabetes. In turn, hypertension and diabetes were related to cerebrovascular disease. Finally, cerebrovascular disease was associated with lower cortical thickness and volume and higher subcortical volumes, but also cognitive deficits (largest significant pcorrected = 0.02). CONCLUSIONS: We show that adiposity is related to poor cognition, with metabolic consequences of obesity and cerebrovascular disease as potential mediators. The outcomes have clinical implications, supporting a role for the management of adiposity in the prevention of late-life dementia and cognitive decline.
CONTEXT: Chronic obesity is associated with several complications, including cognitive impairment and dementia. However, we have only piecemeal knowledge of the mechanisms linking obesity to central nervous system damage. Among candidate mechanisms are other elements of obesity-associated metabolic syndrome, such as hypertension, dyslipidemia, and diabetes, but also systemic inflammation. While there have been several neuroimaging studies linking adiposity to changes in brain morphometry, a comprehensive investigation of the relationship has so far not been done. OBJECTIVE: To identify links between adiposity and cognitive dysfunction. METHODS: This observational cohort study (UK Biobank), with an 8-year follow-up, included more than 20 000 participants from the general community, with a mean age of 63 years. Only participants with data available on both baseline and follow-up timepoints were included. The main outcome measures were cognitive performance and mediator variables: hypertension, diabetes, systemic inflammation, dyslipidemia, gray matter measures, and cerebrovascular disease (volume of white matter hyperintensities on magnetic resonance imaging). RESULTS: Using structural equation modeling, we found that body mass index, waist-to-hip ratio, and body fat percentage were positively related to higher plasma C-reactive protein, dyslipidemia, hypertension, and diabetes. In turn, hypertension and diabetes were related to cerebrovascular disease. Finally, cerebrovascular disease was associated with lower cortical thickness and volume and higher subcortical volumes, but also cognitive deficits (largest significant pcorrected = 0.02). CONCLUSIONS: We show that adiposity is related to poor cognition, with metabolic consequences of obesity and cerebrovascular disease as potential mediators. The outcomes have clinical implications, supporting a role for the management of adiposity in the prevention of late-life dementia and cognitive decline.
Authors: F-E de Leeuw; J C de Groot; M Oudkerk; J C M Witteman; A Hofman; J van Gijn; M M B Breteler Journal: Brain Date: 2002-04 Impact factor: 13.501
Authors: Keenan A Walker; Melinda C Power; Ron C Hoogeveen; Aaron R Folsom; Christie M Ballantyne; David S Knopman; B Gwen Windham; Elizabeth Selvin; Clifford R Jack; Rebecca F Gottesman Journal: Stroke Date: 2017-11-03 Impact factor: 7.914
Authors: Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Frank Telang Journal: Philos Trans R Soc Lond B Biol Sci Date: 2008-10-12 Impact factor: 6.237
Authors: N Medic; H Ziauddeen; K D Ersche; I S Farooqi; E T Bullmore; P J Nathan; L Ronan; P C Fletcher Journal: Int J Obes (Lond) Date: 2016-03-22 Impact factor: 5.095
Authors: Benjamin S Aribisala; Maria C Valdés Hernández; Natalie A Royle; Zoe Morris; Susana Muñoz Maniega; Mark E Bastin; Ian J Deary; Joanna M Wardlaw Journal: Eur Radiol Date: 2012-11-01 Impact factor: 5.315
Authors: Lisa Ronan; Aaron F Alexander-Bloch; Konrad Wagstyl; Sadaf Farooqi; Carol Brayne; Lorraine K Tyler; Paul C Fletcher Journal: Neurobiol Aging Date: 2016-07-27 Impact factor: 4.673
Authors: Ilona Papousek; Elisabeth M Weiss; Manfred G Moertl; Karin Schmid-Zalaudek; Edina Krenn; Verena Lessiak; Helmut K Lackner Journal: Behav Sci (Basel) Date: 2021-04-18
Authors: Anne Tüngler; Sandra Van der Auwera; Katharina Wittfeld; Stefan Frenzel; Jan Terock; Nele Röder; Georg Homuth; Henry Völzke; Robin Bülow; Hans Jörgen Grabe; Deborah Janowitz Journal: Sci Rep Date: 2021-12-20 Impact factor: 4.379
Authors: Jonathan H Burdette; Mohsen Bahrami; Paul J Laurienti; Sean L Simpson; Barbara J Nicklas; Jason Fanning; W Jack Rejeski Journal: Obesity (Silver Spring) Date: 2022-04 Impact factor: 9.298